Similar articles

• Update Alert 2: Remdesivir for Adults With COVID-19.

  Kaka AS, MacDonald R, Linskens EJ, Wilt TJ. Kaka AS, et al. Ann Intern Med. 2021 Dec;174(12):W114-W115. doi: 10.7326/L21-0600. Epub 2021 Oct 5. Ann Intern Med. 2021. PMID: 34606312 Free PMC article. No abstract available.
• Major Update 2: Remdesivir for Adults With COVID-19.

  Kaka AS, Wilt TJ. Kaka AS, et al. Ann Intern Med. 2022 Aug;175(8):W81-W82. doi: 10.7326/L22-0212. Ann Intern Med. 2022. PMID: 35969873 No abstract available.
• Safety profile of the antiviral drug remdesivir: An update.

  Fan Q, Zhang B, Ma J, Zhang S. Fan Q, et al. Biomed Pharmacother. 2020 Oct;130:110532. doi: 10.1016/j.biopha.2020.110532. Epub 2020 Jul 22. Biomed Pharmacother. 2020. PMID: 32707440 Free PMC article. Review. No abstract available.
• Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2).

  Qaseem A, Yost J, Etxeandia-Ikobaltzeta I, Abraham GM, Jokela JA, Miller MC, Forciea MA, Humphrey LL; Scientific Medical Policy Committee of the American College of Physicians*. Qaseem A, et al. Ann Intern Med. 2021 Dec;174(12):W116-W117. doi: 10.7326/L21-0607. Epub 2021 Oct 5. Ann Intern Med. 2021. PMID: 34606308 Free PMC article. No abstract available.
• Remdesivir as a broad-spectrum antiviral drug against COVID-19.

  Hong YN, Xu J, Sasa GBK, Zhou KX, Ding XF. Hong YN, et al. Eur Rev Med Pharmacol Sci. 2021 Jan;25(1):541-548. doi: 10.26355/eurrev_202101_24426. Eur Rev Med Pharmacol Sci. 2021. PMID: 33506946 Review.